Jim Simons Palisade Bio, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.11 - $83.85 $52,562 - $40.1 Million
477,840 Added 1395.97%
512,070 $51,000
Q2 2022

Aug 12, 2022
BUY
$0.41 - $1.04 $5,301 - $13,447
12,930 Added 60.7%
34,230 $14,000
Q1 2022

May 13, 2022
SELL
$0.81 - $1.51 $48,466 - $90,350
-59,835 Reduced 73.75%
21,300 $23,000
Q4 2021

Feb 11, 2022
BUY
$1.3 - $2.96 $105,475 - $240,159
81,135 New
81,135 $105,000
Q3 2021

Nov 12, 2021
SELL
$2.35 - $3.93 $341,455 - $571,029
-145,300 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$3.49 - $11.34 $507,097 - $1.65 Million
145,300 New
145,300 $591,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email